Insulin receptor-sensitising polyaminosterols as a novel therapeutic approach for the treatment of type 2 diabetes

被引：0
|
作者：
Govers, R. [1 ,2 ]
Gonzalez, T. [2 ]
Zaarour, N. [2 ]
Berenguer, M. [2 ]
Le Marchand-Brustel, Y. [3 ]
Tanti, J. -F. [3 ]
Bost, F. [3 ]
Corcelle, V. [3 ]
Zhang, J. [4 ]
Xu, T. [4 ]
Brunel, J. M. [5 ]
机构：
[1] INRA, UMR 1260, INSERM, U1062, Marseille, France
[2] Fac Med Nice, INSERM, U895, F-06034 Nice, France
[3] Fac Med Nice, INSERM, U1065, F-06034 Nice, France
[4] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China
[5] CRCM, CNRS, UMR U7258, Marseille, France
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
606
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [31] Focus on insulin resistance in type 2 diabetes: Therapeutic implications
    Reusch, JEB
    DIABETES EDUCATOR, 1998, 24 (02): : 188 - 193
  • [32] Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
    Mackenzie, Richard W. A.
    Elliott, Bradley T.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 55 - 64
  • [33] ITCA 650 provides a novel therapeutic approach to treating patients with type 2 diabetes
    Whitson, A.
    Azeem, R.
    Alessi, T.
    Baron, M. A.
    DIABETOLOGIA, 2016, 59 : S362 - S362
  • [34] A STEPWISE APPROACH TO INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND BASAL INSULIN TREATMENT FAILURE
    Davidson, Mayer B.
    Raskin, Philip
    Tanenberg, Robert J.
    Vlajnic, Aleksandra
    Hollander, Pricilla
    ENDOCRINE PRACTICE, 2011, 17 (03) : 395 - 403
  • [35] Testing a novel dual receptor agonist for treatment of type 2 diabetes mellitus
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (12) : 687 - 687
  • [36] Testing a novel dual receptor agonist for treatment of type 2 diabetes mellitus
    Claire Greenhill
    Nature Reviews Endocrinology, 2018, 14 : 687 - 687
  • [37] Insulin glulisine - Treatment of type 1 and type 2 diabetes
    Sorbera, LA
    Leeson, PA
    DRUGS OF THE FUTURE, 2003, 28 (11) : 1055 - 1058
  • [38] Insulin glargine in the treatment of type 1 and type 2 diabetes
    Barnett, Anthony
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (01) : 59 - 67
  • [39] Insulin detemir in the treatment of type 1 and type 2 diabetes
    Philips, Jean-Christophe
    Scheen, Andre
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (03) : 277 - 283
  • [40] Novel therapeutics for type 2 diabetes: insulin resistance
    Altaf, Q. -A.
    Barnett, A. H.
    Tahrani, A. A.
    DIABETES OBESITY & METABOLISM, 2015, 17 (04): : 319 - 334
12345